| Filed On | Filing |
|---|---|
| 10 Nov 2026 | 10-Q |
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
REDWOOD CITY, Calif. – November 10, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended September 30, ... |
| 04 Nov 2026 |
Form 4: Endweiss Charles, VP Financial Planning Analysis
Received 35,000 shares as a grant or award · Granted 65,000 Employee Stock Option (right to buy) |
| 02 Nov 2026 | SCHEDULE 13D |
| 29 Oct 2026 |
8-K: Other Events
REDWOOD CITY, Calif., October 29, 2026 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of Directors (the “Special Committee”) ... |
| 08 Oct 2026 |
Form 3: Endweiss Charles, VP Financial Planning Analysis
Holds 107,641 shares of Common Stock |
| 18 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 19 Aug 2026 |
Form 4: Horn David R., PRESIDENT & CFO
Sold 7,309 shares ($14.8K) |
| 11 Aug 2026 | 10-Q |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
REDWOOD CITY, Calif. – August 11, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended June 30, 2026. |
| 31 Jul 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Omid Farokhzad, M.D.Chief Executive OfficerSeer, Inc.3800 Bridge Parkway, Redwood City, CA 94065 |
| 31 Jul 2026 |
8-K: Other Events
Omid Farokhzad, M.D.Chief Executive OfficerSeer, Inc.3800 Bridge ParkwayRedwood City, CA 94065 |
| 30 Jul 2026 |
Form 4: Roelofs Nicolas H Phd, Director
Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy) |
| 30 Jul 2026 |
Form 4: Ro Isaac, Director
Received 12,375 shares as a grant or award · Granted 18,750 Stock Option (right to buy) |
| 30 Jul 2026 |
Form 4: Nishar Dipchand, Director
Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy) |
| 30 Jul 2026 |
Form 4: Mcguire Terrance, Director
Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy) |
| 30 Jul 2026 |
Form 4: Langer Robert, Director
Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy) |
| 30 Jul 2026 |
Form 4: Gulyani Meeta, Director
Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy) |
| 28 Jul 2026 | DFAN14A |
| 24 Jul 2026 | DFAN14A |
Loading...